Hagan, Holly

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010

Murray, C. J. L., Vos, T., Lozano, R., Naghavi, M., Flaxman, A. D., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J. A., Abdalla, S., et al. (2012) · The Lancet

Global Health and EpidemiologyHealth Systems, Economic Evaluations, Quality of Life

Cited by 8,888

Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

Vos, T., Flaxman, A. D., Naghavi, M., Lozano, R., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J. A., Abdalla, S., Aboyans, V., et al. (2012) · The Lancet

Global Health and EpidemiologyHealth Systems, Economic Evaluations, Quality of Life

Cited by 8,291

Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013

Vos, T., Barber, R. M., Bell, B., Bertozzi-Villa, A., Biryukov, S., Bolliger, I., Charlson, F., Davis, A., Degenhardt, L., Dicker, D., et al. (2015) · The Lancet

Global Health and EpidemiologyInsurance, Mortality, Demography, Risk Management

Cited by 6,414

Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013

Forouzanfar, M. H., Alexander, L., Anderson, H. R., Bachman, V. F., Biryukov, S., Brauer, M., Burnett, R., Casey, D., Coates, M. M., Cohen, A., et al. (2015) · The Lancet

Cardiovascular Health and Risk FactorsGlobal Health and Epidemiology

Cited by 2,701

A systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugs

Hagan, H., Pouget, E. R., & Des Jarlais, D. C. (2011) · Journal of Infectious Diseases

HIV, Drug Use, Sexual RiskHepatitis C virus research

Cited by 313

Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990–2001

Des Jarlais, D. C., Perlis, T., Arasteh, K., Torian, L. V., Hagan, H., Beatrice, S., Smith, L., Wethers, J., Milliken, J., Mildvan, D., et al. (2005) · AIDS

HIV, Drug Use, Sexual RiskHepatitis C virus research

Cited by 163

A peer-education intervention to reduce injection risk behaviors for HIV and hepatitis C virus infection in young injection drug users

Garfein, R. S., Golub, E. T., Greenberg, A. E., Hagan, H., Hanson, D. L., Hudson, S. M., Kapadia, F., Latka, M. H., Ouellet, L. J., Purcell, D. W., et al. (2007) · AIDS

HIV, Drug Use, Sexual RiskSubstance Abuse Treatment and Outcomes

Cited by 159

Hepatitis C virus (HCV) disease progression in people who inject drugs (PWID): a systematic review and meta-analysis

Smith, D. J., Combellick, J., Jordan, A. E., & Hagan, H. (2015) · International Journal of Drug Policy

Hepatitis C virus researchHIV, Drug Use, Sexual Risk

Cited by 104

Perceptions of genetic testing and genomic medicine among drug users

Perlman, D. C., Gelpí-Acosta, C., Friedman, S. R., Jordan, A. E., & Hagan, H. (2015) · International Journal of Drug Policy

Pharmacogenetics and Drug MetabolismEthics in Clinical Research

Cited by 12